| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Population-based Study of Immunotherapy-related Toxicities in Lung Cancer
|
Cathcart-Rake, Elizabeth J.
|
|
|
21 |
5 |
p. 421-427.e2
|
artikel
|
| 2 |
Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non–Small-Cell Lung Cancer
|
Miyawaki, Taichi
|
|
|
21 |
5 |
p. e405-e414
|
artikel
|
| 3 |
Association Between RET Fusions and Efficacy of Pemetrexed-based Chemotherapy for Patients With Advanced NSCLC in China: A Multicenter Retrospective Study
|
Shen, Tianle
|
|
|
21 |
5 |
p. e349-e354
|
artikel
|
| 4 |
Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer
|
Chiang, Anne C.
|
|
|
21 |
5 |
p. 455-463.e4
|
artikel
|
| 5 |
Clinical Activity of Afatinib in Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study
|
Moran, Teresa
|
|
|
21 |
5 |
p. 428-436.e2
|
artikel
|
| 6 |
Clinical Utility of Reflex Ordered Testing for Molecular Biomarkers in Lung Adenocarcinoma
|
Anand, Kartik
|
|
|
21 |
5 |
p. 437-442
|
artikel
|
| 7 |
Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study
|
Minari, Roberta
|
|
|
21 |
5 |
p. e464-e473
|
artikel
|
| 8 |
Detection of Meningeal Metastasis in the Cerebrospinal Fluid in Lung Adenocarcinoma: Case Report
|
Zhang, Yijun J.
|
|
|
21 |
5 |
p. e493-e496
|
artikel
|
| 9 |
DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non–Small-Cell Lung Cancer: An External Validation
|
Prelaj, Arsela
|
|
|
21 |
5 |
p. e337-e348
|
artikel
|
| 10 |
Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib
|
Schmid, Sabine
|
|
|
21 |
5 |
p. e488-e492
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
21 |
5 |
p. A1
|
artikel
|
| 12 |
Effect of Hospitalization During First Chemotherapy and Performance Status on Small-cell Lung Cancer Outcomes
|
Rittberg, Rebekah
|
|
|
21 |
5 |
p. e388-e404
|
artikel
|
| 13 |
Efficacy and Safety of Nivolumab in Previously Treated Patients With Non–Small-cell Lung Cancer: Real World Experience in Argentina
|
Martin, Claudio
|
|
|
21 |
5 |
p. e380-e387
|
artikel
|
| 14 |
Elective Nodal Irradiation for Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Practice Patterns
|
Farrell, Matthew J.
|
|
|
21 |
5 |
p. 443-449.e4
|
artikel
|
| 15 |
Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non–small-cell Lung Cancer in China
|
Zhao, Yiming
|
|
|
21 |
5 |
p. e355-e362
|
artikel
|
| 16 |
Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Small-Cell Lung Cancer Patients
|
Gobbini, Elisa
|
|
|
21 |
5 |
p. e497-e510
|
artikel
|
| 17 |
Immune-related Encephalitis in Two Patients Treated With Immune Checkpoint Inhibitor
|
Robert, Lucie
|
|
|
21 |
5 |
p. e474-e477
|
artikel
|
| 18 |
Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non–Small-Cell Lung Cancer
|
Naidoo, Jarushka
|
|
|
21 |
5 |
p. e435-e444
|
artikel
|
| 19 |
Impact of Surveillance After Lobectomy for Lung Cancer on Disease Detection and Survival
|
Mayne, Nicholas R.
|
|
|
21 |
5 |
p. 407-414
|
artikel
|
| 20 |
Incidence and Mortality of Lung Cancer Among Never Smokers in Relationship to Secondhand Smoking: Findings From the PLCO Trial
|
Abdel-Rahman, Omar
|
|
|
21 |
5 |
p. 415-420.e2
|
artikel
|
| 21 |
In Regard to “Activity of EGFR TKIs in Caucasian Patients With NSCLC Harbouring Potentially Sensitive Uncommon EGFR Mutations”
|
Caliman, Enrico
|
|
|
21 |
5 |
p. e363-e365
|
artikel
|
| 22 |
Knowledge, Attitudes, and Practices Pertaining to Lung Cancer Screening Among Primary Care Physicians in a Public Urban Health Network
|
Mukthinuthalapati, V.V. Pavan Kedar
|
|
|
21 |
5 |
p. 450-454
|
artikel
|
| 23 |
Lung Cancer Screening: Characteristics of Nonparticipants and Potential Screening Barriers
|
Raju, Shine
|
|
|
21 |
5 |
p. e329-e336
|
artikel
|
| 24 |
Mediastinal Up-Staging During Surgery in Non–Small-Cell Lung Cancer: Which Mediastinal Lymph Node Metastasis Patterns Better Predict The Outcome? A Multicenter Analysis
|
Chiappetta, Marco
|
|
|
21 |
5 |
p. 464-471.e1
|
artikel
|
| 25 |
Pembrolizumab for Previously Treated, PD-L1–expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival
|
Velcheti, Vamsidhar
|
|
|
21 |
5 |
p. e445-e455
|
artikel
|
| 26 |
Radioguided Surgery, a Cost-Effective Strategy for Treating Solitary Pulmonary Nodules: 20-Year Experience of a Single Center
|
Ricciardi, Sara
|
|
|
21 |
5 |
p. e417-e422
|
artikel
|
| 27 |
Real-World Efficacy of First-Line Pembrolizumab in Patients With Advanced or Recurrent Non–Small-Cell Lung Cancer and High PD-L1 Tumor Expression
|
Tambo, Yuichi
|
|
|
21 |
5 |
p. e366-e379
|
artikel
|
| 28 |
Real-World Outcomes for Advanced Non-Small Cell Lung Cancer Patients Treated With a PD-L1 Inhibitor Beyond Progression
|
Stinchcombe, Thomas E.
|
|
|
21 |
5 |
p. 389-394.e3
|
artikel
|
| 29 |
Relationship Between Programmed Death Receptor-Ligand 1 Expression and Response to Checkpoint Inhibitor Immunotherapy in Pulmonary Sarcomatoid Carcinoma: A Pooled Analysis
|
Babacan, Nalan A.
|
|
|
21 |
5 |
p. e456-e463
|
artikel
|
| 30 |
Reply
|
Passaro, Antonio
|
|
|
21 |
5 |
p. e415-e416
|
artikel
|
| 31 |
Skip N2 Metastasis in Pulmonary Adenocarcinoma: Good Prognosis Similar to N1 Disease
|
Wang, Lin
|
|
|
21 |
5 |
p. e423-e434
|
artikel
|
| 32 |
Table of Contents
|
|
|
|
21 |
5 |
p. A2, A4-A8
|
artikel
|
| 33 |
Treatment of Patients With Non–Small-Cell Lung Cancer Harboring Rare Oncogenic Mutations
|
Marmarelis, Melina E.
|
|
|
21 |
5 |
p. 395-406
|
artikel
|
| 34 |
Treatment Patterns and Clinical Outcomes Among Patients With ROS1-rearranged Non–small-cell Lung Cancer Progressing on Crizotinib
|
De Giglio, Andrea
|
|
|
21 |
5 |
p. e478-e487
|
artikel
|
| 35 |
Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer
|
Shiraishi, Yoshimasa
|
|
|
21 |
5 |
p. 472-476
|
artikel
|
Tijdschrift beschrijving